Author

Ryota Ozawa

Observed name: R. Ozawa

Institution: Nagano Red Cross Hospital

Observed institutions: Kameda Medical Center, Nagano Red Cross Hospital, Saitama Cardiovascular and Respiratory Center, National Cancer Center Hospital

ORCID: 0000-0002-9278-0264

Observed ORCID: 0000-0002-9278-0264

OpenAlex ID: A5086944550

C‐PLAN index as a prognostic factor for patients with previously untreated advanced non‐small cell lung cancer who received combination immunotherapy: A multicenter retrospective study

2023 · Kei Sonehara, Ryota Ozawa, et al. · Thoracic Cancer · 12

Evaluation of the association between predictive factors and the development of immune‐related adverse events and prognostic factors for chemoimmunotherapy in patients with non‐small cell lung cancer: A multicenter retrospective study

2024 · Ryota Ozawa, Kei Sonehara, et al. · Cancer Medicine · 7

Predictive Factors Associated with Long-Term Response to Combination Immunotherapy in Patients with Untreated Advanced Non-Small-Cell Lung Cancer: A Multicenter Retrospective Study

2023 · Kei Sonehara, Ryota Ozawa, et al. · Oncology · 5

Two Cases of Primary Rhinovirus Pneumonia with Multiple Pulmonary Nodules

2020 · Yasuhiro Morimoto, Takashi Ishiguro, et al. · Internal Medicine · 5

Two Cases of Primary Human Parainfluenza Virus 1 Pneumonia in Which Bronchoalveolar Lavage Fluid Yielded Human Parainfluenza Virus 1

2019 · Takashi Ishiguro, Yasuhito Kobayashi, et al. · Internal Medicine · 5

Prognostic Value of the Geriatric Nutritional Risk Index in Previously Untreated Patients with Advanced Non-Small Cell Lung Cancer Treated with a Combination Therapy of Anti-PD-1/-PD-L1 Antibodies and Platinum-Based Chemotherapy: A Multicenter Retrospective Study

2024 · Taro Hirabayashi, Kei Sonehara, et al. · Oncology · 3

Clinical course and findings of 14 patients with COVID-19 compared with 5 patients with conventional human coronavirus pneumonia

2020 · Takashi Ishiguro, Kenji Takano, et al. · Respiratory Medicine Case Reports · 2

[Successful Treatment of Squamous Cell Lung Cancer without PD-L1 Expression Using Fourth-Line Nivolumab].

2019 · Ryota Ozawa, Hiroshi Kuraishi, et al. · PubMed · 1

Pulmonary Leukocytoclastic Vasculitis Associated with Myelodysplastic Syndrome

2026 · Ryota Ozawa, Midori Sato, et al. · Internal Medicine

Evaluation of Screening for Pulmonary Hypertension Associated With Chronic Respiratory Disease

2025 · S. Hirota, H. Kuraishi, et al. · American Journal of Respiratory and Critical Care Medicine

The effect of nutritional status and motivational status on activities of daily living in patients with cancer

2024 · H. Kemmochi, R. Ozawa, et al. · Clinical Nutrition ESPEN

309P Expression of estrogen receptor is a negative predictive biomarker for immunotherapy with lenvatinib plus pembrolizumab for advanced endometrial cancer with pMMR

2023 · H. Fujii, T. Nishikawa, et al. · Annals of Oncology

Pulmonary Epithelioid Hemangioendothelioma in a Patient with Liver Metastases After Approximately Eight Years' Follow-up

2023 · Kimihiro Sato, Hiroshi Kuraishi, et al. · Haigan

An Anaplastic Lymphoma Kinase-rearranged Squamous Cell Lung Cancer Treated with Sequential ALK-tyrosine Kinase Inhibitor Therapy: a Case Report

2022 · Ryota Ozawa, Hiroshi Kuraishi, et al. · Haigan

Pulmonary Vasodilator Therapy of Pulmonary Hypertension in Patients with Chronic Lung Diseases

2020 · S. Hirota, H. Kuraishi, et al. · American Journal of Respiratory and Critical Care Medicine

Works count: 15

Citation count: 40

H-index: 5

I10-index: 1